Equity Overview
Price & Market Data
Price: $7.07
Daily Change: $0.00 / 0.00%
Daily Range: $7.07 - $7.07
Market Cap: $188,109,164
Daily Volume: 100
Performance Metrics
1 Week: 1.00%
1 Month: 1.00%
3 Months: 26.70%
6 Months: 20.34%
1 Year: 63.66%
YTD: %
Company Details
Employees: 102
Sector: Health technology
Industry: Medical specialties
Country:
Details
Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreement with Richard Wolf GmbH to develop and commercialize a 4K LED high-definition reusable blue light cystoscope based on Richard Wolf's System blue technology. It sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. The company operates in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, rest of the Europe, Canada, and the United States. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.